Table 1.
Characteristics | n (%) | Characteristics | n (%) |
---|---|---|---|
Gender | Lymph node metastasis location | ||
Male | 32 (58.2) | Axila | 15 (60.0) |
Female | 23 (41.8) | Groin | 10 (40.0) |
Race | Lymph node metastasis treatment | ||
Caucasian | 49 (89.1) | Linphadenectomy | 28 (93.3) |
African | 6 (10.9) | No treatment | 2 (6.7) |
Residence | Local or lymph node recurrence after lymphadenectomy | ||
Rural | 9 (16.4) | No | 13 (46.4) |
Urban | 46 (83.6) | Local | 8 (28.6) |
Lymph node | 7 (25.0) | ||
Chronic sun exposure | Distant metastasis | ||
Yes | 27 (49.1) | No | 58 (92.1) |
No | 12 (21.8) | Cutaneous | 1 (1.6) |
n.a. | 16 (29.1) | Visceral | 4 (6.3) |
Anatomical localization | Lymph node metastasis treatment | ||
Lower extremities | 22 (40.0) | Linphadenectomy | 24 (96.0) |
Upper extremities | 23 (41.8) | No treatment | 1 ( 4.0) |
Trunk | 10 (18.2) | ||
Non-cancer previous lesion | Tumor grade | ||
Yes | 13 (23.6) | I | 25 (45.5) |
No | 42 (76.4) | II | 27 (49.0) |
III | 3 (5.5) | ||
T classification | Intratumoral lymphocitic infiltrate | ||
T3 | 33 (60.0) | Negative | 12 (21.8) |
T4 | 22 (40.0) | Positive | 43 (78.2) |
N classification | Peritumoral lymphocitic infiltrate | ||
N0 | 41 (74.5) | Negative | 9 (16.4) |
N1 | 14 (25.5) | Positive | 46 (83.6) |
Clinical stage | Vascular infiltrate | ||
II | 27 (49.1) | Negative | 48 (87.3) |
III | 28 (50.9) | Positive | 7 (12.7) |
Treatment of primary tumor | Perineural infiltrate | ||
surgery | Negative | 54 (98.2) | |
Local resection with primary closure | 1 ( 1.9) | Positive | 1 (1.8) |
Local resection with reconstruction | 18 (32.7) | ||
Amputation/disarticulation | 21 (38.2) | ||
Local resection with open wound | 5 ( 9.1) | ||
Radiation therapy | 8 (14.5) | ||
No treatment | 2 (3.6) |
n.a.: not available.